The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oocyte Cryopreservation Market Research Report 2024

Global Oocyte Cryopreservation Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1706811

No of Pages : 81

Synopsis

Human oocyte cryopreservation (egg freezing) is a procedure to preserve a woman's eggs (oocytes).The eggs are extracted, frozen and stored. The intention of the procedure is that the woman may choose to have the eggs thawed, fertilized, and transferred to the uterus as embryos to facilitate a pregnancy in the future.

The global Oocyte Cryopreservation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

America is the largest region market with more than 75% market share in oocyte cryopreservation industry in Canada and USA regions.

Top players are Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates, CCRM IVF, HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group), Kindbody, West Coast Fertility Centers etc. Revenue of Canada and USA players accounted for more than 75% of total value in 2019. Prelude Fertility is the leader manufacturer in Canada and USA oocyte cryopreservation market with the market share about 20% in 2019.

This report aims to provide a comprehensive presentation of the global market for Oocyte Cryopreservation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oocyte Cryopreservation.

Report Scope

The Oocyte Cryopreservation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oocyte Cryopreservation market comprehensively. Regional market sizes, concerning products by Type, by Customer, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oocyte Cryopreservation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Customer, and by regions.
Market Segmentation

By Company

  • Prelude Fertility
  • CReATe Fertility Center
  • Anova Fertility
  • San Diego Fertility Center (SDFC)
  • Extend Fertility
  • Shady Grove Fertility
  • Mayo Clinic
  • Reproductive Biology Associates
  • CCRM IVF
  • HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
  • Kindbody
  • West Coast Fertility Centers

Segment by Type

  • Slow-cooling Method
  • Flash-freezing Process (Vitrification)

Segment by Customer

  • 25-30 Year Old Female
  • 30-35 Year Old Female
  • 35-40 Year Old Female
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Customer, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oocyte Cryopreservation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Customer, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oocyte Cryopreservation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Slow-cooling Method
1.2.3 Flash-freezing Process (Vitrification)
1.3 Market by Customer
1.3.1 Global Oocyte Cryopreservation Market Growth by Customer: 2019 VS 2023 VS 2030
1.3.2 25-30 Year Old Female
1.3.3 30-35 Year Old Female
1.3.4 35-40 Year Old Female
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oocyte Cryopreservation Market Perspective (2019-2030)
2.2 Oocyte Cryopreservation Growth Trends by Region
2.2.1 Global Oocyte Cryopreservation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oocyte Cryopreservation Historic Market Size by Region (2019-2024)
2.2.3 Oocyte Cryopreservation Forecasted Market Size by Region (2025-2030)
2.3 Oocyte Cryopreservation Market Dynamics
2.3.1 Oocyte Cryopreservation Industry Trends
2.3.2 Oocyte Cryopreservation Market Drivers
2.3.3 Oocyte Cryopreservation Market Challenges
2.3.4 Oocyte Cryopreservation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oocyte Cryopreservation Players by Revenue
3.1.1 Global Top Oocyte Cryopreservation Players by Revenue (2019-2024)
3.1.2 Global Oocyte Cryopreservation Revenue Market Share by Players (2019-2024)
3.2 Global Oocyte Cryopreservation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oocyte Cryopreservation Revenue
3.4 Global Oocyte Cryopreservation Market Concentration Ratio
3.4.1 Global Oocyte Cryopreservation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oocyte Cryopreservation Revenue in 2023
3.5 Oocyte Cryopreservation Key Players Head office and Area Served
3.6 Key Players Oocyte Cryopreservation Product Solution and Service
3.7 Date of Enter into Oocyte Cryopreservation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oocyte Cryopreservation Breakdown Data by Type
4.1 Global Oocyte Cryopreservation Historic Market Size by Type (2019-2024)
4.2 Global Oocyte Cryopreservation Forecasted Market Size by Type (2025-2030)
5 Oocyte Cryopreservation Breakdown Data by Customer
5.1 Global Oocyte Cryopreservation Historic Market Size by Customer (2019-2024)
5.2 Global Oocyte Cryopreservation Forecasted Market Size by Customer (2025-2030)
6 North America
6.1 North America Oocyte Cryopreservation Market Size (2019-2030)
6.2 North America Oocyte Cryopreservation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oocyte Cryopreservation Market Size by Country (2019-2024)
6.4 North America Oocyte Cryopreservation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oocyte Cryopreservation Market Size (2019-2030)
7.2 Europe Oocyte Cryopreservation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oocyte Cryopreservation Market Size by Country (2019-2024)
7.4 Europe Oocyte Cryopreservation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oocyte Cryopreservation Market Size (2019-2030)
8.2 Asia-Pacific Oocyte Cryopreservation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oocyte Cryopreservation Market Size by Region (2019-2024)
8.4 Asia-Pacific Oocyte Cryopreservation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oocyte Cryopreservation Market Size (2019-2030)
9.2 Latin America Oocyte Cryopreservation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oocyte Cryopreservation Market Size by Country (2019-2024)
9.4 Latin America Oocyte Cryopreservation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oocyte Cryopreservation Market Size (2019-2030)
10.2 Middle East & Africa Oocyte Cryopreservation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oocyte Cryopreservation Market Size by Country (2019-2024)
10.4 Middle East & Africa Oocyte Cryopreservation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Prelude Fertility
11.1.1 Prelude Fertility Company Detail
11.1.2 Prelude Fertility Business Overview
11.1.3 Prelude Fertility Oocyte Cryopreservation Introduction
11.1.4 Prelude Fertility Revenue in Oocyte Cryopreservation Business (2019-2024)
11.1.5 Prelude Fertility Recent Development
11.2 CReATe Fertility Center
11.2.1 CReATe Fertility Center Company Detail
11.2.2 CReATe Fertility Center Business Overview
11.2.3 CReATe Fertility Center Oocyte Cryopreservation Introduction
11.2.4 CReATe Fertility Center Revenue in Oocyte Cryopreservation Business (2019-2024)
11.2.5 CReATe Fertility Center Recent Development
11.3 Anova Fertility
11.3.1 Anova Fertility Company Detail
11.3.2 Anova Fertility Business Overview
11.3.3 Anova Fertility Oocyte Cryopreservation Introduction
11.3.4 Anova Fertility Revenue in Oocyte Cryopreservation Business (2019-2024)
11.3.5 Anova Fertility Recent Development
11.4 San Diego Fertility Center (SDFC)
11.4.1 San Diego Fertility Center (SDFC) Company Detail
11.4.2 San Diego Fertility Center (SDFC) Business Overview
11.4.3 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Introduction
11.4.4 San Diego Fertility Center (SDFC) Revenue in Oocyte Cryopreservation Business (2019-2024)
11.4.5 San Diego Fertility Center (SDFC) Recent Development
11.5 Extend Fertility
11.5.1 Extend Fertility Company Detail
11.5.2 Extend Fertility Business Overview
11.5.3 Extend Fertility Oocyte Cryopreservation Introduction
11.5.4 Extend Fertility Revenue in Oocyte Cryopreservation Business (2019-2024)
11.5.5 Extend Fertility Recent Development
11.6 Shady Grove Fertility
11.6.1 Shady Grove Fertility Company Detail
11.6.2 Shady Grove Fertility Business Overview
11.6.3 Shady Grove Fertility Oocyte Cryopreservation Introduction
11.6.4 Shady Grove Fertility Revenue in Oocyte Cryopreservation Business (2019-2024)
11.6.5 Shady Grove Fertility Recent Development
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Detail
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Oocyte Cryopreservation Introduction
11.7.4 Mayo Clinic Revenue in Oocyte Cryopreservation Business (2019-2024)
11.7.5 Mayo Clinic Recent Development
11.8 Reproductive Biology Associates
11.8.1 Reproductive Biology Associates Company Detail
11.8.2 Reproductive Biology Associates Business Overview
11.8.3 Reproductive Biology Associates Oocyte Cryopreservation Introduction
11.8.4 Reproductive Biology Associates Revenue in Oocyte Cryopreservation Business (2019-2024)
11.8.5 Reproductive Biology Associates Recent Development
11.9 CCRM IVF
11.9.1 CCRM IVF Company Detail
11.9.2 CCRM IVF Business Overview
11.9.3 CCRM IVF Oocyte Cryopreservation Introduction
11.9.4 CCRM IVF Revenue in Oocyte Cryopreservation Business (2019-2024)
11.9.5 CCRM IVF Recent Development
11.10 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
11.10.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Company Detail
11.10.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Business Overview
11.10.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Introduction
11.10.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Revenue in Oocyte Cryopreservation Business (2019-2024)
11.10.5 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Development
11.11 Kindbody
11.11.1 Kindbody Company Detail
11.11.2 Kindbody Business Overview
11.11.3 Kindbody Oocyte Cryopreservation Introduction
11.11.4 Kindbody Revenue in Oocyte Cryopreservation Business (2019-2024)
11.11.5 Kindbody Recent Development
11.12 West Coast Fertility Centers
11.12.1 West Coast Fertility Centers Company Detail
11.12.2 West Coast Fertility Centers Business Overview
11.12.3 West Coast Fertility Centers Oocyte Cryopreservation Introduction
11.12.4 West Coast Fertility Centers Revenue in Oocyte Cryopreservation Business (2019-2024)
11.12.5 West Coast Fertility Centers Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’